Cargando…
Enterohepatic bacterial infections dysregulate the FGF15-FGFR4 endocrine axis
BACKGROUND: Enterohepatic bacterial infections have the potential to affect multiple physiological processes of the body. Fibroblast growth factor 15/19 (FGF15 in mice, FGF19 in humans) is a hormone that functions as a central regulator of glucose, lipid and bile acid metabolism. FGF15/19 is produce...
Autores principales: | Romain, Guillaume, Tremblay, Sarah, Arena, Ellen T, Antunes, L Caetano M, Covey, Scott, Chow, Michael T, Finlay, B Brett, Menendez, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818973/ https://www.ncbi.nlm.nih.gov/pubmed/24165751 http://dx.doi.org/10.1186/1471-2180-13-238 |
Ejemplares similares
-
Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
por: Yang, Chaofeng, et al.
Publicado: (2012) -
The Role of FGF19 and MALRD1 in Enterohepatic Bile Acid Signaling
por: Wang, Linda X., et al.
Publicado: (2022) -
Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis
por: Zhang, Jinglin, et al.
Publicado: (2019) -
Chlorogenic Acid Inhibits Lipid Deposition by Regulating the Enterohepatic FXR-FGF15 Pathway
por: Ye, Xiaolin, et al.
Publicado: (2022) -
Targeting the FGF/FGFR axis and its co-alteration allies
por: Uehara, Y., et al.
Publicado: (2022)